CRANBURY, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Innophos Holdings, Inc., the parent company of Innophos, Inc., today announced its initial public offering of 8,695,652 shares of common stock priced at $12.00 per share. Innophos Holdings, Inc. also granted the underwriters an option to purchase up to an additional 1,304,348 shares at the initial public offering price to cover allotments, if any.
The shares are trading on The NASDAQ Stock Market under the symbol "IPHS."
Credit Suisse Securities (USA) LLC, Bear, Stearns & Co. Inc. and UBS Securities LLC are acting as joint book running managers.
A registration statement relating to these securities was declared effective as of November 2, 2006 by the U.S. Securities and Exchange Commission. Copies of the prospectus relating to this offering may be obtained from Credit Suisse Securities (USA) LLC, Prospectus Department, Eleven Madison Avenue, Level 1B, New York, New York 10010, (212) 325-2580 or Bear, Stearns & Co. Inc., Prospectus Department, 383 Madison Avenue, New York, New York 10179 or UBS Investment Bank, Prospectus Department, 299 Park Avenue, New York, New York 10171, (212) 821-3000. In addition, a copy of the registration statement is available on the U.S. Securities and Exchange Commission website at http://www.sec.gov/.
Innophos is one of the leading North American manufacturers of specialty phosphates, serving a diverse range of customers across multiple applications, geographies and channels. Innophos offers a broad suite of products used in a wide variety of food and beverage, consumer products, pharmaceutical and industrial applications.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Innophos Holdings, Inc.
Innophos Holdings, Inc., the parent company of Innophos, Inc., (http://www.innophos.com/) is one of the leading North American manufacturers of specialty phosphates, serving a diverse range of customers across multiple applications, geographies and channels. Innophos offers a broad suite of products used in a wide variety of food and beverage, consumer products, pharmaceutical and industrial applications. Innophos' market-leading positions derive from its experience and dedication to customer service and innovation. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Port Maitland, ON (Canada); and Coatzacoalcos, Veracruz and Mission Hills, Guanajuato (Mexico).
Safe Harbor for Forward-Looking and Cautionary Statements
This press release and the documents referred to herein contain forward- looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. As such, final results could differ from estimates or expectations due to risks and uncertainties, including but not limited to: incomplete or preliminary information; changes in government regulations and policies; continued acceptance of Innophos' products and services in the marketplace; competitive factors; technological changes; Innophos' dependence upon third- party suppliers; and other risks. For any of these factors, Innophos claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, as amended.
